Affidea B.V. provides diagnostics investigations, clinical laboratory, and cancer treatment services to customers in Central and Eastern Europe.
The company offers radiological diagnostics; hematology testing services that include blood counts and coagulation tests; chemical testing, such as glucose levels, lipidemic profiles, iron status, and cholesterol levels; endocrinology testing that comprise thyroid function testing and sex hormone levels; immunology testing, including tests for infectious and autoimmune diseases; microbiology testing, which include cultures in body fluid and sensitivity tests to antibiotics; cytology testing that comprise PAP tests to cervical smears; urine microscopic and chemical analysis; and tumor markers for diagnosis and monitoring specific cancer, such as PSA for prostrate cancer, CA153 for breast, and CA 19-9 for colon cancer.
It also provides special endocrinological and immunological testing; special allergy testing; molecular biology testing for the detection of inherited and infectious diseases; specialized testing in oncology developed for prevention, diagnosis, and treatment of cancer; and toxicological testing for poisonous chemicals and controlled substance drugs.
Affidea B.V. was formerly known as Euromedic International N.V. and changed its name to Affidea B.V. in January 2015. The company was founded in 1991 and is based in Amsterdam, the Netherlands. It operates diagnostic and cancer care centers in Bosnia, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Ireland, Italy, Lithuania, Poland, Portugal, Romania, Switzerland, and Turkey.
Our Assignment in the Nutshell
Ms. Eva Johnson was contracted by the central social media agency (1EM) to further improve the social media communication of the HQ of Affidea B.V. and it subsidies.